Citations

Citations to this article as recorded by  

• Gut Microbiota and Their Metabolites as Modulators of Vascular Complications in Diabetes
  Meng Duan, Jielu Wen, Anning Chen, Sifan Chen
  Health and Metabolism.2025; : 2.     CrossRef
• Systematic Review of the Effectiveness of Common Probiotic Strains: Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus, and Lactobacillus sporogenes in the Management of Diabetes
  Basavaraj G. Sooragonda, Preyander Thakur, Rajesh Moganti, Arpit Garg, Umesh Kumar Garg
  Journal of Diabetology.2025; 16(1): 29.     CrossRef
• Opportunistic Features of Non-Clostridium botulinum Strains Containing bont Gene Cluster
  Tomasz Grenda, Anna Grenda, Anna Jakubczyk, Kamila Rybczyńska-Tkaczyk
  Pathogens.2024; 13(9): 780.     CrossRef

Over a hundred billion bacteria are found in human intestines. This has emerged as an environmental factor in metabolic diseases, such as obesity and related diseases. The majority of these bacteria belong to two dominant phyla, Bacteroidetes and Firmicutes. Since the ratio of Firmicutes to Bacteroidetes increases in people with obesity and in various animal models, it has been assumed that phylum composition causes the increase in occurrence of metabolic diseases over the past decade. However, this assumption has been challenged by recent studies that have found even an opposite association of phylum composition within metabolic diseases. Moreover, the gut microbiota affects host energy metabolism in various ways including production of metabolites and interaction with host intestinal cells to regulate signaling pathways that affect energy metabolism. However, the direct effect of gut bacteria on host energy intake, such as energy consumption by the bacteria itself and its effects on intestinal energy absorption, has been underestimated. This review aims to discuss whether increased ratio of Firmicutes to Bacteroidetes is associated with the development of metabolic diseases, and whether energy competition between the bacteria and host is a missing part of the mechanism linking gut microbiota to metabolic diseases.

Citations

Citations to this article as recorded by  

• Resistant starch inhibits high-fat diet-induced oncogenic responses in the colon of C57BL/6 mice
  Huawei Zeng, Bryan D. Safratowich, Zhenhua Liu, Michael R. Bukowski
  The Journal of Nutritional Biochemistry.2025; : 109838.     CrossRef
• Dietary Bacillus improves behavior, intestinal health, and growth of juvenile sea cucumbers Apostichopus japonicus at low temperature
  Peng Ding, Xiang Li, Xiyuan Huang, Yushi Yu, Zihe Zhao, Huiyan Wang, Xiajing Wang, Jun Ding, Yaqing Chang, Chong Zhao
  Journal of Thermal Biology.2025; 127: 104053.     CrossRef
• Behavior, intestinal health, and growth of small sea cucumbers Apostichopus japonicus in different color morphs
  Peng Ding, Yushi Yu, Zihe Zhao, Xiang Li, Xiajing Wang, Huiyan Wang, Xiyuan Huang, Jun Ding, Chong Zhao
  Marine Environmental Research.2024; 193: 106300.     CrossRef
• Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in db/db mice via gut microbiota modulation
  Li-Wei Zhang, Li-Li Zhu, Xiao-Yun Zhu, Shou-Qiang Fu, Xi-Ming Liu
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Repeated inoculation with rumen fluid accelerates the rumen bacterial transition with no benefit on production performance in postpartum Holstein dairy cows
  Fanlin Kong, Feiran Wang, Yijia Zhang, Shuo Wang, Wei Wang, Shengli Li
  Journal of Animal Science and Biotechnology.2024;[Epub]     CrossRef
• Combining bioinformatics and multiomics strategies to investigate the key microbiota and active components of Liupao tea ameliorating hyperlipidemia
  Hailin Zhou, Xuancheng Wang, Zhiyong She, Li Huang, Huijie Wei, Shanyi Yang, Zhijuan Wei, Hongwei Chen, Bao Yang, Zehua Hu, Xue Feng, Pingchuan Zhu, Zijian Li, Jiahui Shen, Huan Liu, Huanxiao Dong, Guanghui Chen, Qisong Zhang
  Journal of Ethnopharmacology.2024; 333: 118438.     CrossRef
• Petunidin-3-O-[rhamnopyranosyl-(trans-p-coumaroyl)]-5-O-(β-D-glucopyranoside), the main anthocyanin from the fruits of Lycium ruthenicum murray, enhances the lifespan of Caenorhabditis elegans by activating DAF-16 and improving the gut microbiota
  Kangzhi Zhang, Jiahao Zhu, Peiyun Liu, Renpeng Guo, Yamei Yan, Jia Mi, Lu Lu, Youlong Cao, Xiaoxiong Zeng
  Food Bioscience.2024; 61: 104642.     CrossRef
• Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes
  Sabitha Sasidharan Pillai, Charles A Gagnon, Christy Foster, Ambika P Ashraf
  The Journal of Clinical Endocrinology & Metabolism.2024; 109(11): 2709.     CrossRef
• Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review
  Roman Maslennikov, Nona Benuni, Anna Levshina, Farida Adzhieva, Tatyana Demina, Alina Kucher, Ekaterina Pervushova, Evgeniya Yuryeva, Elena Poluektova, Oxana Zolnikova, Evgenii Kozlov, Alexey Sigidaev, Vladimir Ivashkin
  Microorganisms.2024; 12(8): 1678.     CrossRef
• Testosterone treatment impacts the intestinal microbiome of transgender individuals
  Rebecca M. Harris, Fernanda Pace, Thomas M. Kuntz, Xochitl C. Morgan, Phoebe Hyland, Kiana Summers, Em McDermott, Kai Blumen, Paula I. Watnick, Vincent B. Young
  mSphere.2024;[Epub]     CrossRef
• Analysis of Oral Microbiota in Elderly Thai Patients with Alzheimer’s Disease and Mild Cognitive Impairment
  Narongrit Sritana, Atitaya Phungpinij
  International Journal of Environmental Research and Public Health.2024; 21(9): 1242.     CrossRef
• Gut microbiota-derived tryptophan metabolites regulated by Wuji Wan to attenuate colitis through AhR signaling activation
  Wanghui Jing, Sijing Dong, Yinyue Xu, Jingjing Liu, Jiawei Ren, Xue Liu, Min Zhu, Menggai Zhang, Hehe Shi, Na Li, Peng Xia, Haitao Lu, Sicen Wang
  Acta Pharmaceutica Sinica B.2024;[Epub]     CrossRef
• Identification of oncogenic signatures in the inflammatory colon of C57BL/6 mice fed a high-fat diet
  Huawei Zeng, Bryan D. Safratowich, Wen-Hsing Cheng, Michael R. Bukowski
  The Journal of Nutritional Biochemistry.2023; 111: 109188.     CrossRef
• Evaluation of the gut microbiome alterations in healthy rats after dietary exposure to different synthetic ZnO nanoparticles
  Xinyi Zhu, Henghui Li, Liuzhu Zhou, Huijun Jiang, Minghui Ji, Jin Chen
  Life Sciences.2023; 312: 121250.     CrossRef
• Microplastic-induced gut microbiota and serum metabolic disruption in Sprague-Dawley rats
  Nan Zhao, Meirong Zhao, Hangbiao Jin
  Environmental Pollution.2023; 320: 121071.     CrossRef
• Effects of neutral polysaccharide from Platycodon grandiflorum on high-fat diet-induced obesity via the regulation of gut microbiota and metabolites
  Jing Song, Qin liu, Mengqi Hao, Xiaohu Zhai, Juan Chen
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Metabolite interactions between host and microbiota during health and disease: Which feeds the other?
  Yan Zhang, Rui Chen, DuoDuo Zhang, Shuang Qi, Yan Liu
  Biomedicine & Pharmacotherapy.2023; 160: 114295.     CrossRef
• Connecting Gut Microbial Diversity with Plasma Metabolome and Fecal Bile Acid Changes Induced by the Antibiotics Tobramycin and Colistin Sulfate
  Aishwarya Murali, Varun Giri, Franziska Maria Zickgraf, Philipp Ternes, Hunter James Cameron, Saskia Sperber, Volker Haake, Peter Driemert, Hennicke Kamp, Dorothee Funk-Weyer, Shana J. Sturla, Ivonne M.C.M. Rietjens, Bennard van Ravenzwaay
  Chemical Research in Toxicology.2023; 36(4): 598.     CrossRef
• Short-Term Alternate Feeding between Terrestrially Sourced Oil- and Fish Oil-Based Diets Modulates the Intestinal Microecology of Juvenile Turbot
  Xiuhua Ma, Yaoyao Kong, Houguo Xu, Qingzhu Bi, Mengqing Liang, Kangsen Mai, Yanjiao Zhang
  Biology.2023; 12(5): 650.     CrossRef
• Effects and action mechanisms of lotus leaf (Nelumbo nucifera) ethanol extract on gut microbes and obesity in high-fat diet-fed rats
  Zhang Yanan, Ma Lu, Zhang Lu, Huo Jinhai, Wang Weiming
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Effects of coffee with different roasting degrees on obesity and related metabolic disorders
  Claudia I. Gamboa-Gómez, Laura J. Barragán-Zúñiga, Fernando Guerrero-Romero, Gerardo Martínez-Aguilar, José Luis Gónzalez, Almendra A. Valenzuela-Ramírez, Juan A. Rojas-Contreras, Monica Anese, Maribel Cervantes Flores, Marilisa Alongi
  Journal of Functional Foods.2023; 111: 105889.     CrossRef
• Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
  Roman Maslennikov, Elena Poluektova, Oxana Zolnikova, Alla Sedova, Anastasia Kurbatova, Yulia Shulpekova, Natyia Dzhakhaya, Svetlana Kardasheva, Maria Nadinskaia, Elena Bueverova, Vladimir Nechaev, Anna Karchevskaya, Vladimir Ivashkin
  International Journal of Molecular Sciences.2023; 24(22): 16502.     CrossRef
• Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High‐Fat Diet‐Fed Mice
  Mengjie Li, Yuhan Zhao, Yanan Wang, Ruixuan Geng, Jingjing Fang, Seong‐Gook Kang, Kunlun Huang, Tao Tong
  Molecular Nutrition & Food Research.2022;[Epub]     CrossRef
• Heimao tea polysaccharides ameliorate obesity by enhancing gut microbiota-dependent adipocytes thermogenesis in mice fed with high fat diet
  Yu Wang, Ting Li, Yueyue Liu, Chengcheng Yang, Lei Liu, Xiangnan Zhang, Xingbin Yang
  Food & Function.2022; 13(24): 13014.     CrossRef
• The Interplay of Sex Steroids, the Immune Response, and the Intestinal Microbiota
  Fernanda Pace, Paula I. Watnick
  Trends in Microbiology.2021; 29(9): 849.     CrossRef
• Heat stress on microbiota composition, barrier integrity, and nutrient transport in gut, production performance, and its amelioration in farm animals
  Amlan Kumar Patra, Indrajit Kar
  Journal of Animal Science and Technology.2021; 63(2): 211.     CrossRef
• Mechanisms linking gut microbial metabolites to insulin resistance
  Hye Rim Jang, Hui-Young Lee
  World Journal of Diabetes.2021; 12(6): 730.     CrossRef
• The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health
  Lenka Tomasova, Marian Grman, Karol Ondrias, Marcin Ufnal
  Nutrition & Metabolism.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Natural compounds as obesity pharmacotherapies
  Xin‐Yuan Zhao, Ji‐Qiu Wang, G. Gregory Neely, Yan‐Chuan Shi, Qiao‐Ping Wang
  Phytotherapy Research.2024; 38(2): 797.     CrossRef
• Druggability, molecular targets, and nanocarrier delivery of natural triterpenoid celastrol against chronic diseases
  Chi Lui Chan, Yilu Sun, Xiaowen Mao, Hansen Chen, Jia Zhao, Jianhui Rong
  Acta Materia Medica.2024;[Epub]     CrossRef
• Celastrol functions as an emerging manager of lipid metabolism: Mechanism and therapeutic potential
  Jia Gu, Ya-Ning Shi, Neng Zhu, Hong-Fang Li, Chan-Juan Zhang, Li Qin
  Biomedicine & Pharmacotherapy.2023; 164: 114981.     CrossRef
• Tripterygium hypoglaucum extract ameliorates adjuvant-induced arthritis in mice through the gut microbiota
  Jianghui HU, Jimin NI, Junping ZHENG, Yanlei GUO, Yong YANG, Cheng YE, Xiongjie SUN, Hui XIA, Yanju LIU, Hongtao LIU
  Chinese Journal of Natural Medicines.2023; 21(10): 730.     CrossRef
• Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation
  Lili Su, Zhifan Hong, Tong Zhou, Yuanyuan Jian, Mei Xu, Xuanping Zhang, Xiaoyan Zhu, Jiayin Wang
  Scientific Reports.2022;[Epub]     CrossRef
• Tripterygium hypoglaucum (Levl.) Hutch: A systematic review of its traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology
  Jiangping Wei, Liyun Chen, Sijia Gao, Jirui Wang, Yunhong Wang, Zhiwei Zhang, Yuyu Zhang, Xiaomei Zhang, Yong Yang, Dajian Yang
  Pharmacological Research - Modern Chinese Medicine.2022; 3: 100094.     CrossRef
• Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms
  Mengzhen Li, Faren Xie, Lu Wang, Guoxue Zhu, Lian-Wen Qi, Shujun Jiang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway
  Pingping Chen, Bin Wang, Meng Li, Chunxue Cui, Fei Liu, Yonggang Gao
  Computational and Structural Biotechnology Journal.2022; 20: 3173.     CrossRef
• [Retracted] Investigating Celastrol’s Anti‐DCM Targets and Mechanisms via Network Pharmacology and Experimental Validation
  Rui Xi, Yongxin Wan, Lihong Yang, Jingying Zhang, Liu Yang, Shuai Yang, Rui Chai, Fengchen Mu, Qiting Sun, Rui Yan, Zhifang Wu, Sijin Li, Zhijun Liao
  BioMed Research International.2022;[Epub]     CrossRef
• Celastrol inhibits TXNIP expression to protect pancreatic β cells in diabetic mice
  Si-wei Wang, Tian Lan, Fang Zheng, Hui Huang, Hang-fei Chen, Qi Wu, Feng Zhang
  Phytomedicine.2022; 104: 154316.     CrossRef
• Celastrol: A Promising Agent Fighting against Cardiovascular Diseases
  Zhexi Li, Jingyi Zhang, Xulei Duan, Guoan Zhao, Min Zhang
  Antioxidants.2022; 11(8): 1597.     CrossRef
• Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion
  Carlos A. Fuzo, Ronaldo B. Martins, Thais F. C. Fraga‐Silva, Martin K. Amstalden, Thais Canassa De Leo, Juliano P. Souza, Thais M. Lima, Lucia H. Faccioli, Débora Noma Okamoto, Maria Aparecida Juliano, Suzelei C. França, Luiz Juliano, Vania L. D. Bonato,
  Drug Development Research.2022; 83(7): 1623.     CrossRef
• In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates
  Mahmoud Saad Abdel-Halim, Momen Askoura, Basem Mansour, Galal Yahya, Amira M. El-Ganiny
  The Journal of Antibiotics.2022; 75(12): 679.     CrossRef
• Celastrol alleviates metabolic disturbance in high‐fat diet‐induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation
  Xueping Yang, Fan Wu, Lingli Li, Ernest C. Lynch, Linglin Xie, Yan Zhao, Ke Fang, Jingbin Li, Jinlong Luo, Lijun Xu, Xin Zou, Fuer Lu, Guang Chen
  Phytotherapy Research.2021; 35(1): 297.     CrossRef
• Celastrol in metabolic diseases: Progress and application prospects
  Shaohua Xu, Yaqian Feng, Weishen He, Wen Xu, Wei Xu, Hongjun Yang, Xianyu Li
  Pharmacological Research.2021; 167: 105572.     CrossRef
• The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism
  Qijing Fan, Furong Xu, Bin Liang, Xiaoju Zou
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Serum Metabolome Mediates the Antiobesity Effect of Celastrol-Induced Gut Microbial Alterations
  Shaohua Xu, Liwei Lyu, Huaichang Zhu, Xiaoqiang Huang, Wei Xu, Wen Xu, Yaqian Feng, Yong Fan
  Journal of Proteome Research.2021; 20(10): 4840.     CrossRef
• Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CLpro of COVID-19 and Acts as Superoxide Radical Scavenger
  Francesco Caruso, Manrose Singh, Stuart Belli, Molly Berinato, Miriam Rossi
  International Journal of Molecular Sciences.2020; 21(23): 9266.     CrossRef

Citations

Citations to this article as recorded by  

• Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment
  Liyang Jia, Shiqiong Huang, Boyu Sun, Yongguang Shang, Chunsheng Zhu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Phenolics from endophytic fungi as natural α-glucosidase inhibitors: A comprehensive review
  Muhammad Imran Tousif, Saba Tauseef, Sadeer Nabeelah, Jugreet Sharmeen, Gokhan Zengin, Lesetja Legoabe, Muhammad Imran, Mohamad Fawzi Mahomoodally
  Journal of Molecular Structure.2023; 1291: 135852.     CrossRef
• Ligand-targeted fishing of α-glucosidase inhibitors from Tribulus terrestris L. based on chitosan-functionalized multi-walled carbon nanotubes with immobilized α-glucosidase
  Xin Meng, Hou Zong, Zhong Zheng, Junpeng Xing, Zhiqiang Liu, Fengrui Song, Shu Liu
  Analytical and Bioanalytical Chemistry.2023; 415(14): 2677.     CrossRef
• Isolation, structure elucidation, and biological activities of sesquiterpenes and phthalides from two edible mushrooms Pleurotus species
  Jewel C De Padua, Emi Fukushima-Sakuno, Kotomi Ueno, Thomas Edison E dela Cruz, Atsushi Ishihara
  Bioscience, Biotechnology, and Biochemistry.2023; 87(12): 1429.     CrossRef
• Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
  Dongmei Wang, Jieying Liu, Liyuan Zhou, Qian Zhang, Ming Li, Xinhua Xiao
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• 18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice
  Yiming Ma, Xinyi Du, Dandan Zhao, Kegong Tang, Xiaona Wang, Shaoting Guo, Xiaobei Li, Song Mei, Na Sun, Jiaqi Liu, Chengyu Jiang
  Biochemical and Biophysical Research Communications.2021; 579: 168.     CrossRef

Citations

Citations to this article as recorded by  

• Bletilla striata polysaccharides alleviate metabolic dysfunction-associated steatotic liver disease through enhancing hepatocyte RelA/ HNF1α signaling
  Yi-Huai He, Li-Li Ou, Jin-Lian Jiang, Yun-Fen Chen, Aikedaimu Abudukeremu, Yuan Xue, Mao-Yuan Mu, Wei-Wei Zhong, De-Lin Xu, Xuan-Yu Meng, Ya-Qun Guan
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
  Yijia Song, Sutong Liu, Lihui Zhang, Wenxia Zhao, Yuanmei Qin, Minghao Liu
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Bifidobacterium bifidum BGN4 fractions ameliorate palmitic acid-induced hepatocyte ferroptosis by inhibiting SREBP1-CYP2E1 pathway
  Guangkui Bu, Gang Chen, Juan Li, Dan Wu, Jiangtao Liao
  Journal of Investigative Medicine.2024; 72(1): 67.     CrossRef
• Docosahexaenoic acid (DHA) alleviates hepatic lipid accumulation by regulating mitochondrial quality control through ERK signaling pathway in grass carp (Ctenopharyngodon idellus)
  Chenchen Bian, Shanghong Ji, Caihong Zeng, Jian Sun, Gen Kaneko, Hong Ji
  Aquaculture.2024; 579: 740209.     CrossRef
• Characterisation and skin protection activities of polysaccharides from Schnabelia terniflora
  Ying Zhao, Yixian Liu, Huoxiang Zhou, Wei Guo, Weidong Wang, Huiping Chen
  Natural Product Research.2024; 38(23): 4191.     CrossRef
• Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study
  Lubo Shi, Xiaoduo Liu, Enze Li, Shutian Zhang, Anni Zhou
  Journal of Clinical Lipidology.2024; 18(5): e797.     CrossRef
• Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity
  Oladayo Emmanuel Apalowo, Grace Adeola Adegoye, Tolulope Mobolaji Obuotor
  Current Issues in Molecular Biology.2024; 46(3): 1810.     CrossRef
• Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
  Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yu Zhang, Qian Cao, Mengque Xu
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota
  Wenkai Zhang, Longhui Yu, Qinru Yang, Jinfeng Zhang, Wenjing Wang, Xinru Hu, Jingen Li, Guodong Zheng
  Phytomedicine.2024; 127: 155478.     CrossRef
• Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
  Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
  Gut Microbes.2024;[Epub]     CrossRef
• Prospect of research on anti-atherosclerosis effect of main components of traditional Chinese medicine Yiqi Huoxue Huatan recipe through gut microbiota: A review
  Hongtao Huang, Hanjun Zhao, Lv Wenqing, Feiyue Xu, Xiaolong Wang, Yili Yao, Yu Huang
  Medicine.2024; 103(5): e37104.     CrossRef
• Polysaccharides from Eucommia ulmoides Oliv. Leaves Alleviate Acute Alcoholic Liver Injury by Modulating the Microbiota–Gut–Liver Axis in Mice
  Yingzhi Li, Huimei Wang, Xueping Leng, Jiaming Gao, Chang Li, Danfei Huang
  Foods.2024; 13(7): 1089.     CrossRef
• Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
  Feng Zhang, Jiaming Ju, Hongtao Diao, Jinglun Song, Yu bian, Baofeng Yang
  British Journal of Pharmacology.2024;[Epub]     CrossRef
• Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
  Dongliang Chen, Yuanfei Wang, Jianmei Yang, Wanyi Ou, Guiru Lin, Ze Zeng, Xiaomin Lu, Zumin Chen, Lili Zou, Yaling Tian, Aiping Wu, Shelley E. Keating, Qinhe Yang, Chenli Lin, Yinji Liang
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: insights from microbiome and metabolomics
  Xinyi Cheng, Yang Hu, Jun Kuang, Xiaoquan Guo, Huabin Cao, Huansheng Wu, Guoliang Hu, Yu Zhuang
  Poultry Science.2024; 103(8): 103968.     CrossRef
• Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
  Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei
  Biomedicines.2024; 12(7): 1398.     CrossRef
• The molecular and network mechanisms of antilipidemic potential effects of Ganfule capsules in nonalcoholic fatty liver disease
  Yu Pan, Liya Qiao, Yunkun Zhang, Suren R. Sooranna, Danna Huang, Min Ou, Fei Xu, Lu Chen, Dan Huang
  Heliyon.2024; 10(14): e34297.     CrossRef
• Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators
  Lara Pires, Ana M. González-Paramás, Sandrina A. Heleno, Ricardo C. Calhelha
  Antibiotics.2024; 13(8): 720.     CrossRef
• Polysaccharide-mediated modulation of gut microbiota in the treatment of liver diseases: Promising approach with significant challenges
  Yang Yang, Guifang Fan, Jianhang Lan, Xin Li, Xiaojiaoyang Li, Runping Liu
  International Journal of Biological Macromolecules.2024; 280: 135566.     CrossRef
• Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease
  Huafeng Chen, Shengzhe Yan, Qianru Xiang, Jiamin Liang, Xuejian Deng, Wanqin He, Yanzhen Cheng, Li Yang
  BMC Complementary Medicine and Therapies.2024;[Epub]     CrossRef
• Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism
  Xu Dong, Yu-Ting Xiong, Tingting He, Congyang Zheng, Junjie Li, Yingjie Zhuang, Yingjie Xu, Ye Xiu, Zhixin Wu, Xiaomei Zhao, Xiaohe Xiao, Zhaofang Bai, Lili Gao
  Genes & Nutrition.2024;[Epub]     CrossRef
• Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
  Junyi Chen, Shuzhan Yang, Hanxia Luo, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Feiyue Chen, Danning Xu, Nan Cao
  International Immunopharmacology.2024; 141: 113014.     CrossRef
• Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
  Hao CHEN, Yang ZHOU, Haiping HAO, Jing XIONG
  Chinese Journal of Natural Medicines.2024; 22(8): 724.     CrossRef
• Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future
  Shehzeen Noor, Shaukat Ali, Muhammad Summer, Anfah Riaz, Laiba Nazakat, Aqsa
  Probiotics and Antimicrobial Proteins.2024;[Epub]     CrossRef
• Danshen polysaccharides alleviate AFB1 induced Jejunal injury
  Lu Zhang, Xincheng Gong, Shijia Zhang, Chanchan Cui, Qiongyi Zhang, Xiao Wang, Wanyu Shi, Yongzhan Bao
  Ecotoxicology and Environmental Safety.2024; 285: 117115.     CrossRef
• Edible fungi polysaccharides modulate gut microbiota and lipid metabolism: A review
  Huanyi Xu, Zhixiang Xue, Pengyi Wang, Quancen Lee, Zihui Chen, Bin Liu, Xiaoyan Liu, Feng Zeng
  International Journal of Biological Macromolecules.2024; 283: 137427.     CrossRef
• Modulation of efferocytosis and inflammation resolution by live and non-live probiotics through gut microbiota interactions in preclinical and clinical studies
  Mona Arianejad, Farnaz Tajeddini, Mina Zareardalan, Fatemeh Hosseinpour-Soleimani, Mohsen Sisakht, Amir Tajbakhsh, Mohammad-Taha Pirsalehi, Manica Negahdaripour
  Food Bioscience.2024; 62: 105498.     CrossRef
• Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
  Hui Han, Yi Jiang, Mengyu Wang, Mebratu Melaku, Lei Liu, Yong Zhao, Nadia Everaert, Bao Yi, Hongfu Zhang
  Critical Reviews in Food Science and Nutrition.2023; 63(12): 1689.     CrossRef
• Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance
  Clement Agboyibor, Jianshu Dong, Clement Yaw Effah, Emmanuel Kwateng Drokow, Maxwell Ampomah-Wireko, Waqar Pervaiz, Augustina Sangmor, Xinli Ma, Jian Li, Hong-Min Liu, Peng Zhang
  Biomedicine & Pharmacotherapy.2023; 157: 113934.     CrossRef
• Salvia miltiorrhiza polysaccharides alleviate florfenicol-induced inflammation and oxidative stress in chick livers by regulating phagosome signaling pathway
  Xiao Wang, Wei Liu, Di Zhang, Yulan Jiao, Qianhui Zhao, Ying Liu, Wanyu Shi, Yongzhan Bao
  Ecotoxicology and Environmental Safety.2023; 249: 114428.     CrossRef
• Preparation methods, structural characteristics, and biological activity of polysaccharides from Salvia miltiorrhiza: A review
  Yuanyuan Li, Xin Zhang, Yining Li, Pei Yang, Zhiyuan Zhang, Hang Wu, Lihao Zhu, Yuhong Liu
  Journal of Ethnopharmacology.2023; 305: 116090.     CrossRef
• The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial
  Dengcheng Hui, Lu Liu, Nisma Lena Bahaji Azami, Jingru Song, Yanping Huang, Wan Xu, Chao Wu, Dong Xie, Yulang Jiang, Yanqin Bian, Mingyu Sun
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
  Xiaoyu Huang, Yi Yang, Xueli Li, Xiaoya Zhu, Dan Lin, Yueran Ma, Min Zhou, Xiangyi Cui, Bingyu Zhang, Dongmei Dang, Yuhong Lü, Changwu Yue
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Polysaccharides from Ostrea rivularis rebuild the balance of gut microbiota to ameliorate non-alcoholic fatty liver disease in ApoE−/− mice
  Lijun Zhu, Mingmei Xiao, Jigang Luo, Shijie Li, Wenting Liu, Jinchuan Wu, Zhuoyue Song
  International Journal of Biological Macromolecules.2023; 235: 123853.     CrossRef
• Improvement of Inflammation, Diabetes, and Obesity by Forest Product-Derived Polysaccharides through the Human Intestinal Microbiota
  Seong-woo MYEONG, Yong Ju LEE, Do Hyun KIM, Tae-Jong KIM
  Journal of the Korean Wood Science and Technology.2023; 51(5): 358.     CrossRef
• Recent developments in Salvia miltiorrhiza polysaccharides: Isolation, purification, structural characteristics and biological activities
  Lei Luo, Juan Xue, Zheng Shao, Zhang Zhou, Wenqian Tang, Jinxin Liu, Hongfei Hu, Fan Yang
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease
  Huihui Lv, Feiyue Tao, Lingling Peng, Shufang Chen, Zhongyue Ren, Jiahui Chen, Bo Yu, Hua Wei, Cuixiang Wan
  Nutrients.2023; 15(6): 1355.     CrossRef
• Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro
  Jin Chen, Guoping Zhu, Wenbo Xiao, Xiaosong Huang, Kewu Wang, Yi Zong
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 779.     CrossRef
• Managing metabolic diseases: The roles and therapeutic prospects of herb-derived polysaccharides
  Xinmei Xu, Lijie Wang, Kun Zhang, Yi Zhang, Gang Fan
  Biomedicine & Pharmacotherapy.2023; 161: 114538.     CrossRef
• Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits
  Huan Wang, Cuicui Ma, Yan Li, Lei Zhang, lima A, Chengcong Yang, Feiyan Zhao, Haifeng Han, Dongyang Shang, Fan Yang, Yuying Zhang, Heping Zhang, Zhihong Sun, Ruifang Guo, Yuan Pin Hung
  Microbiology Spectrum.2023;[Epub]     CrossRef
• Sea cucumber sulfated polysaccharides and Lactobacillus gasseri synergistically ameliorate the overweight induced by altered gut microbiota in mice
  Zhengqi Liu, Chunqing Ai, Xinping Lin, Xiaoming Guo, Shuang Song, Beiwei Zhu
  Food & Function.2023; 14(9): 4106.     CrossRef
• Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats
  Xingjian Wen, Hejing Liu, Xiaoling Luo, Li Lui, Jiuyu Fan, Yajing Xing, Jia Wang, Xingfang Qiao, Na Li, Guixue Wang
  Frontiers in Microbiology.2023;[Epub]     CrossRef
• Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
  Ling Ye, Shicheng Fan, Pengfei Zhao, Chenghua Wu, Menghua Liu, Shuang Hu, Peng Wang, Hongyu Wang, Huichang Bi
  Acta Pharmaceutica Sinica B.2023; 13(9): 3598.     CrossRef
• α‐Lactalbumin Peptide Asp‐Gln‐Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids‐Treated HepG2 Cells and High‐Fat Diet‐Induced NAFLD Mice by Activating the PPARα Pathway
  Haoran Chen, Yanfeng Ma, Xiaofen Qi, Jianjun Tian, Ying Ma, Tianjiao Niu
  Molecular Nutrition & Food Research.2023;[Epub]     CrossRef
• Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′‐monophosphate‐activated protein kinase pathway and reshaping gut microbiota
  Chao Han, Zongshuo Li, Ruiying Liu, Zihan Zhao, Yu Wang, Xuli Zuo, Yushi Zhang, Zeyu Geng, Houyu Huang, Xiuzhen Pan, Weidong Li
  Journal of the Science of Food and Agriculture.2023; 103(15): 7721.     CrossRef
• Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
  Qin Guo, Yun Li, Xin Dai, Bangmao Wang, Jie Zhang, Hailong Cao
  Nutrients.2023; 15(17): 3722.     CrossRef
• Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
  Alejandra Mijangos-Trejo, Natalia Nuño-Lambarri, Varenka Barbero-Becerra, Misael Uribe-Esquivel, Paulina Vidal-Cevallos, Norberto Chávez-Tapia
  International Journal of Molecular Sciences.2023; 24(19): 14918.     CrossRef
• Repair Effect and Mechanism of Electrospinning Nanocomposite Material with Gelatin-Bletilla Striata Gum/Salvia Miltiorrhiza on Orthopedic Refractory Wounds
  Geliang Hu, Ming Deng, Yonggang Ma, Jianghua Ming
  Journal of Biomedical Nanotechnology.2023; 19(10): 1783.     CrossRef
• Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study
  Hong Pan, Baocheng Liu, Xin Luo, Xinxin Shen, Jijia Sun, An Zhang
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review
  Henan Zhang, Fuchun Jiang, Jinsong Zhang, Wenhan Wang, Lin Li, Jingkun Yan
  International Journal of Biological Macromolecules.2022; 204: 169.     CrossRef
• Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
  Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao
  Bioengineered.2022; 13(3): 5216.     CrossRef
• Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
  Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Do
  Biomedicines.2022; 10(3): 550.     CrossRef
• Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Yu Hu, Zhen Ye, Yingqi She, Linzhen Li, Mingquan Wu, Kaihua Qin, Yuzheng Li, Haiqing He, Zhipeng Hu, Maoyi Yang, Fating Lu, Qiaobo Ye
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
  Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets
  Jie Liu, Yun Shi, Daiyin Peng, Lei Wang, Nianjun Yu, Guokai Wang, Weidong Chen
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
  Yijing Ren, Siyue Li, Zixuan Song, Qiuping Luo, Yingying Zhang, Hao Wang
  Nutrients.2022; 14(11): 2303.     CrossRef
• Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis
  Yuhang Li, Juxiong Liu, Bojian Ye, Yueyao Cui, Ruiqi Geng, Shu Liu, Yufei Zhang, Wenjin Guo, Shoupeng Fu
  Journal of Agricultural and Food Chemistry.2022; 70(34): 10620.     CrossRef
• Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
  Mingmei Shao, Yifei Lu, Hongjiao Xiang, Junmin Wang, Guang Ji, Tao Wu
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• The chemistry and efficacy benefits of polysaccharides from Atractylodes macrocephala Koidz
  Congying Liu, Shengguang Wang, Zedong Xiang, Tong Xu, Mengyuan He, Qing Xue, Huaying Song, Peng Gao, Zhufeng Cong
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies
  Min-Han Chi, Jung Chao, Chien-Yu Ko, Shyh-Shyun Huang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Three water soluble polysaccharides with anti-inflammatory activities from Selaginella uncinata (Desv.) Spring
  Haochen Hui, Meng Gao, Xuerong Zhao, Lianhong Yin, Lina Xu, Lili Li, Jinyong Peng
  International Journal of Biological Macromolecules.2022; 222: 1983.     CrossRef
• Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
  Xiang Chen, Menghan Liu, Jun Tang, Ning Wang, Yibin Feng, Haotian Ma
  International Journal of Molecular Sciences.2022; 23(19): 11710.     CrossRef
• Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet
  Sai Wang, Xin-Yu Li, Hong-Fang Ji, Liang Shen
  Life Sciences.2022; 310: 121110.     CrossRef
• Structural Alteration of Gut Microbiota During the Amelioration of Chronic Psychological Stress-Aggravated Diabetes-Associated Cognitive Decline by a Traditional Chinese Herbal Formula, ZiBu PiYin Recipe
  Wen Zhou, Libin Zhan, Huiying Xu, Lijing Zhang
  Journal of Alzheimer's Disease.2022; 90(4): 1465.     CrossRef
• Bacillus amyloliquefaciens SC06 in the diet improves egg quality of hens by altering intestinal microbiota and the effect is diminished by antimicrobial peptide
  Shujie Xu, Fei Wang, Peng Zou, Xiang Li, Qian Jin, Qi Wang, Baikui Wang, Yuanhao Zhou, Li Tang, Dongyou Yu, Weifen Li
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Effect of stigma maydis polysaccharide on the gut microbiota and transcriptome of VPA induced autism model rats
  Xiaolei Yang, Jiyuan Li, Yang Zhou, Ning Zhang, Jicheng Liu
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism
  Zi-Li Ai, Xian Zhang, Wei Ge, You-Bao Zhong, Hai-Yan Wang, Zheng-Yun Zuo, Duan-Yong Liu
  World Journal of Gastroenterology.2022; 28(43): 6131.     CrossRef
• Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
  Fang Xie, Hang-fei Xu, Jing Zhang, Xiao-ni Liu, Bu-xin Kou, Meng-yin Cai, Jing Wu, Jin-ling Dong, Qing-hua Meng, Yi Wang, Dexi Chen, Yang Zhang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Structural elucidation and anti-nonalcoholic fatty liver disease activity of Polygonatum cyrtonema Hua polysaccharide
  Wei Liu, Taili Shao, Lei Tian, Zhengrui Ren, Lan Gao, Zhiyan Tang, Zheng Fang, Pingchuan Yuan, Chunyan Liu, Jikun Li, Guodong Wang, Jun Han
  Food & Function.2022; 13(24): 12883.     CrossRef
• The protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice via mediating the FXR/LXRα pathway
  Shaotong Ma, Xinyi Pang, Shuhua Tian, Jing Sun, Qiaobin Hu, Xiangfei Li, Yingjian Lu
  Food & Function.2022; 13(24): 12966.     CrossRef
• Gut Microbiota is A Crucial Bridge Mediating the Pharmacological Effect of Labiatae Traditional Chinese Medicine
  Yanan Yang, Fang Zhang, Jiaqi Yu, Chongming Wu
  Diseases and Research.2022; 2(1): 13.     CrossRef
• Suppression of obesity and inflammation by polysaccharide from sporoderm-broken spore of Ganoderma lucidum via gut microbiota regulation
  Tingting Sang, Chengjie Guo, Dandan Guo, Jianjun Wu, Yujie Wang, Ying Wang, Jiajun Chen, Chaojie Chen, Kaikai Wu, Kun Na, Kang Li, Liu Fang, Cuiling Guo, Xingya Wang
  Carbohydrate Polymers.2021; 256: 117594.     CrossRef
• Annual review of LSD1/KDM1A inhibitors in 2020
  Dong-Jun Fu, Jun Li, Bin Yu
  European Journal of Medicinal Chemistry.2021; 214: 113254.     CrossRef
• Diet-Regulating Microbiota and Host Immune System in Liver Disease
  Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min
  International Journal of Molecular Sciences.2021; 22(12): 6326.     CrossRef
• Lactobacillus johnsonii BS15 combined with abdominal massage on intestinal permeability in rats with nonalcoholic fatty liver and cell biofilm repair
  Wei Zhang, Huanan Li, Na Zhao, Xiongfei Luo, Siwen Liu, an Bao, Yingying Chen, Haiteng Wang, Junshi Wang, Jingui Wang
  Bioengineered.2021; 12(1): 6354.     CrossRef
• Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
  Hang-Yu Li, Dan-Dan Zhou, Ren-You Gan, Si-Yu Huang, Cai-Ning Zhao, Ao Shang, Xiao-Yu Xu, Hua-Bin Li
  Nutrients.2021; 13(9): 3211.     CrossRef
• Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis
  Guangqing Cheng, Xiaoni Yan, Fengmeng Wang, Chao Chen, Muhammad Wasim Khan
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes
  Abdul Rahman Conteh, Ruixue Huang
  Toxicology Research.2020; 9(4): 569.     CrossRef
• MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
  Shu Fang, Jie Feng, Hongbin Zhang, Ping Li, Yudan Zhang, Yanmei Zeng, Yingying Cai, Xiaochun Lin, Yaoming Xue, Meiping Guan
  Adipocyte.2020; 9(1): 179.     CrossRef
• Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
  Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Probiyotiklerin Kolon Mikrobiyotasına Etkileri: Güncel Çalışmalar
  Çağlar GÖKIRMAKLI, Zeynep SEYDİM
  Journal of Biotechnology and Strategic Health Research.2020; 4(3): 212.     CrossRef

Diabetes and obesity have reached an epidemic status worldwide. Diabetes increases the risk for cardiovascular disease and non-alcoholic fatty liver disease. Primary bile acids are synthesized in hepatocytes and are transformed to secondary bile acids in the intestine by gut bacteria. Bile acids are nutrient sensors and metabolic integrators that regulate lipid, glucose, and energy homeostasis by activating nuclear farnesoid X receptor and membrane Takeda G protein-coupled receptor 5. Bile acids control gut bacteria overgrowth, species population, and protect the integrity of the intestinal barrier. Gut bacteria, in turn, control circulating bile acid composition and pool size. Dysregulation of bile acid homeostasis and dysbiosis causes diabetes and obesity. Targeting bile acid signaling and the gut microbiome have therapeutic potential for treating diabetes, obesity, and non-alcoholic fatty liver disease.

Citations

Citations to this article as recorded by  

• Sleep deprivation-induced shifts in gut microbiota: Implications for neurological disorders
  Nitu L. Wankhede, Mayur B. Kale, Ashishkumar Kyada, Rekha M M, Kamlesh Chaudhary, K.Satyam Naidu, Sandip Rahangdale, Prajwali V. Shende, Brijesh G. Taksande, Mohammad Khalid, Monica Gulati, Milind J. Umekar, Mohammad Fareed, Spandana Rajendra Kopalli, Sus
  Neuroscience.2025; 565: 99.     CrossRef
• Host metabolism balances microbial regulation of bile acid signalling
  Tae Hyung Won, Mohammad Arifuzzaman, Christopher N. Parkhurst, Isabella C. Miranda, Bingsen Zhang, Elin Hu, Sanchita Kashyap, Jeffrey Letourneau, Wen-Bing Jin, Yousi Fu, Douglas V. Guzior, Randy Longman, Gregory F. Sonnenberg, Ellen Scherl, Robbyn Sockolo
  Nature.2025;[Epub]     CrossRef
• Gut microbiome-derived secondary bile acids: therapeutic targets for reducing cardiovascular disease in type 2 diabetes?
  Sarah A. Johnson, Tiffany L. Weir
  The American Journal of Clinical Nutrition.2024; 119(2): 241.     CrossRef
• Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review
  Soumik Das, V Devi Rajeswari, Ganesh Venkatraman, Ramprasad Elumalai, Sivaraman Dhanasekaran, Gnanasambandan Ramanathan
  Translational Research.2024; 265: 71.     CrossRef
• The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases
  Yuchang Li, Liting Chen, Vassilios Papadopoulos
  Biochimie.2024; 224: 91.     CrossRef
• Variant of the lactase LCT gene explains association between milk intake and incident type 2 diabetes
  Kai Luo, Guo-Chong Chen, Yanbo Zhang, Jee-Young Moon, Jiaqian Xing, Brandilyn A. Peters, Mykhaylo Usyk, Zheng Wang, Gang Hu, Jun Li, Elizabeth Selvin, Casey M. Rebholz, Tao Wang, Carmen R. Isasi, Bing Yu, Rob Knight, Eric Boerwinkle, Robert D. Burk, Rober
  Nature Metabolism.2024; 6(1): 169.     CrossRef
• Predictive value of serum TBA for 2-year MACEs in ACS patients undergoing PCI: a prospective cohort study
  Wen Wen, Qinze Li, Jianqing She, Xiaofang Bai, Lisha Zhang, Ruifeng Li, Yan Wu, Juan Zhou, Zuyi Yuan
  Scientific Reports.2024;[Epub]     CrossRef
• Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
  John C. Rowe, Jenessa A. Winston
  Veterinary Sciences.2024; 11(2): 94.     CrossRef
• The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation
  Olga Golubnitschaja, Jiri Polivka, Pavel Potuznik, Martin Pesta, Ivana Stetkarova, Alena Mazurakova, Lenka Lackova, Peter Kubatka, Martina Kropp, Gabriele Thumann, Carl Erb, Holger Fröhlich, Wei Wang, Babak Baban, Marko Kapalla, Niva Shapira, Kneginja Ric
  EPMA Journal.2024; 15(1): 1.     CrossRef
• Investigating the mechanism of cornel iridoid glycosides on type 2 diabetes mellitus using serum and urine metabolites in rats
  Yadi Hou, Yanmei Huang, Zihui Shang, Shichao Ma, Tianyi Cui, Ali Chen, Yongxia Cui, Suiqing Chen
  Journal of Ethnopharmacology.2024; 328: 118065.     CrossRef
• Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders
  Bandar D. Alrehaili
  Saudi Journal of Gastroenterology.2024; 30(5): 283.     CrossRef
• Cichorium glandulosum Ameliorates HFD-Induced Obesity in Mice by Modulating Gut Microbiota and Bile Acids
  Yewei Zhong, Hurxida Emam, Wenhui Hou, Junlin Yan, Adalaiti Abudurexiti, Rui Zhang, Shuwen Qi, Yi Lei, Xiaoli Ma
  Journal of Medicinal Food.2024; 27(7): 601.     CrossRef
• Exercise Training Independent of Intensity Lowers Plasma Bile Acids in Prediabetes
  STEVEN K. MALIN, U.S. AFSHEEN SYEDA
  Medicine & Science in Sports & Exercise.2024; 56(6): 1009.     CrossRef
• Production of deoxycholic acid by low-abundant microbial species is associated with impaired glucose metabolism
  Annika Wahlström, Ariel Brumbaugh, Wilhelm Sjöland, Lisa Olsson, Hao Wu, Marcus Henricsson, Annika Lundqvist, Kassem Makki, Stanley L. Hazen, Göran Bergström, Hanns-Ulrich Marschall, Michael A. Fischbach, Fredrik Bäckhed
  Nature Communications.2024;[Epub]     CrossRef
• Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
  Yanyan Wang, Huangru Xu, Xiqiao Zhou, Weidong Chen, Huiping Zhou
  Medical Review.2024; 4(4): 262.     CrossRef
• A Mixture of Lactobacillus HY7601 and KY1032 Regulates Energy Metabolism in Adipose Tissue and Improves Cholesterol Disposal in High-Fat-Diet-Fed Mice
  Kippeum Lee, Hyeon-Ji Kim, Joo-Yun Kim, Jae-Jung Shim, Jae-Hwan Lee
  Nutrients.2024; 16(15): 2570.     CrossRef
• Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches
  Shifat-E Ferdous, Jessica M. Ferrell
  International Journal of Molecular Sciences.2024; 25(16): 8731.     CrossRef
• An efficient regioconvergent synthesis of 3-aza-obeticholic acid
  Lawrence D. Harris, Roselis A. Landaeta Aponte, Wanting Jiao, Scott A. Cameron, Alex Weymouth-Wilson, Richard H. Furneaux, Benjamin J. Compton, Andreas Luxenburger
  Steroids.2024; 212: 109517.     CrossRef
• A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents
  Bantayehu Addis Tegegne, Adane Adugna, Aderaw Yenet, Wubetu Yihunie Belay, Yared Yibeltal, Abebe Dagne, Zigale Hibstu Teffera, Gashaw Azanaw Amare, Desalegn Abebaw, Haymanot Tewabe, Rahel Belete Abebe, Tirsit Ketsela Zeleke
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Silicon-Enriched Meat Ameliorates Diabetic Dyslipidemia by Improving Cholesterol, Bile Acid Metabolism and Ileal Barrier Integrity in Rats with Late-Stage Type 2 Diabetes
  Marina Hernández-Martín, Alba Garcimartín, Aránzazu Bocanegra, Adrián Macho-González, Rosa A. García-Fernández, Sonia de Pascual-Teresa, Rocío Redondo-Castillejo, Sara Bastida, Francisco J. Sánchez-Muniz, Juana Benedí, Mª Elvira López-Oliva
  International Journal of Molecular Sciences.2024; 25(21): 11405.     CrossRef
• Unveiling Role of Serum Total Bile Acid in Diabetic Osteopathy, the Unexplored Complication of Diabetes
  Mantu Jain, Chhabi Rani Panda, Paulson Varghese, Saurav Nayak, Sujit Tripathy, Gautom Kumar Saharia, Manaswini Mangaraj
  Indian Journal of Clinical Biochemistry.2024;[Epub]     CrossRef
• Regulation of bile acids and their receptor FXR in metabolic diseases
  Yao Li, Lulu Wang, Qing Yi, Linsong Luo, Yuxia Xiong
  Frontiers in Nutrition.2024;[Epub]     CrossRef
• Editorial: Bile acids in obesity-related diseases
  Yun Shen, Xiaojiao Zheng, Ying Hu, Youping Deng, Qin Xiong
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Improvement of myocardial injury and gut microbiota disturbance in type 2 diabetic mice by inulin with various degrees of polymerization
  Siqiang Jia, Jianpeng Li, Bin Yu, Mengjie Li, Bo Cui
  Food Bioscience.2023; 51: 102318.     CrossRef
• Bile acids and their receptors in regulation of gut health and diseases
  Sen Lin, Sutian Wang, Peng Wang, Cuiming Tang, Zhenjiang Wang, Lian Chen, Guoqing Luo, Hong Chen, Yuntao Liu, Bin Feng, De Wu, Douglas G. Burrin, Zhengfeng Fang
  Progress in Lipid Research.2023; 89: 101210.     CrossRef
• Effects of dietary oat supplementation on carcass traits, muscle metabolites, amino acid profiles, and its association with meat quality of Small-tail Han sheep
  Li-wei Wang, Shao-feng Su, Jie Zhao, Xiao-long He, Shao-yin Fu, Biao Wang, Yun-fei Wang, Da-qing Wang, Na-na Yun, Xin Chen, Damien P Belobrajdic, Terigele, Xiao-dong Li, Li-li Jiang, Jiang-feng He, Yong-bin Liu
  Food Chemistry.2023; 411: 135456.     CrossRef
• Noni (Morinda citrifolia L.) fruit polysaccharide ameliorated high-fat diet-induced obesity by modulating gut microbiota and improving bile acid metabolism
  Wenjing Mo, Jiaqi Zou, Ming Wu, Zijun Peng, Wenjiang He, Wenzhi Li, Xiaoyong Wu
  Journal of Functional Foods.2023; 101: 105408.     CrossRef
• Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
  Jiajia Wu, Yan Chen, Huinan Yang, Leyi Gu, Zhaohui Ni, Shan Mou, Jianxiao Shen, Xiajing Che
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities — preliminary data for PPPM validation
  Martina Kropp, Eline De Clerck, Trong-Tin Kevin Steve Vo, Gabriele Thumann, Vincenzo Costigliola, Olga Golubnitschaja
  EPMA Journal.2023; 14(1): 43.     CrossRef
• Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice
  Kaichi Kasai, Naoya Igarashi, Yuki Tada, Koudai Kani, Shun Takano, Tsutomu Yanagibashi, Fumitake Usui-Kawanishi, Shiho Fujisaka, Shiro Watanabe, Mayuko Ichimura-Shimizu, Kiyoshi Takatsu, Kazuyuki Tobe, Koichi Tsuneyama, Yukihiro Furusawa, Yoshinori Nagai
  International Journal of Molecular Sciences.2023; 24(4): 4050.     CrossRef
• Mitochondrial Cholesterol Metabolites in a Bile Acid Synthetic Pathway Drive Nonalcoholic Fatty Liver Disease: A Revised “Two-Hit” Hypothesis
  Genta Kakiyama, Daniel Rodriguez-Agudo, William M. Pandak
  Cells.2023; 12(10): 1434.     CrossRef
• Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols
  Kevin M. Tveter, Esther Mezhibovsky, Yue Wu, Diana E. Roopchand
  Pharmacology & Therapeutics.2023; 248: 108457.     CrossRef
• Role of liver parameters in diabetes mellitus – a narrative review
  Sana Rafaqat, Aqsa Sattar, Amber Khalid, Saira Rafaqat
  Endocrine Regulations.2023; 57(1): 200.     CrossRef
• Bile acids induce IL-1α and drive NLRP3 inflammasome-independent production of IL-1β in murine dendritic cells
  Ewa Oleszycka, Eoin C. O’Brien, Michael Freeley, Ed C. Lavelle, Aideen Long
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Machine learning for predicting diabetic metabolism in the Indian population using polar metabolomic and lipidomic features
  Nikita Jain, Bhaumik Patel, Manjesh Hanawal, Anurag R. Lila, Saba Memon, Tushar Bandgar, Ashutosh Kumar
  Metabolomics.2023;[Epub]     CrossRef
• Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
  Ahmad Salhab, Johnny Amer, Yinying Lu, Rifaat Safadi
  Gut.2022; 71(7): 1373.     CrossRef
• Comparative Evaluation of the Effect of Metformin and Insulin on Gut Microbiota and Metabolome Profiles of Type 2 Diabetic Rats Induced by the Combination of Streptozotocin and High-Fat Diet
  Nan Hu, Qi Zhang, Hui Wang, Xuping Yang, Yan Jiang, Rong Chen, Liying Wang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Immunomodulatory functions of FXR
  Stefano Fiorucci, Angela Zampella, Patrizia Ricci, Eleonora Distrutti, Michele Biagioli
  Molecular and Cellular Endocrinology.2022; 551: 111650.     CrossRef
• Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota
  Carlos J. Garcia, Vit Kosek, David Beltrán, Francisco A. Tomás-Barberán, Jana Hajslova
  Biomolecules.2022; 12(5): 687.     CrossRef
• Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus
  liying he, Fang-Qing Yang, Pan Tang, Ting-Hui Gao, Cai-Xia Yang, Li Tan, Pan Yue, Ya-Nan Hua, Si-Jing Liu, Jin-Lin Guo
  Biomedicine & Pharmacotherapy.2022; 151: 113091.     CrossRef
• Acrylamide induced glucose metabolism disorder in rats involves gut microbiota dysbiosis and changed bile acids metabolism
  Zonghao Yue, Yanjuan Chen, Qian Dong, Dan Li, Meng Guo, Li Zhang, Yini Shi, Huiting Wu, Lili Li, Zhongke Sun
  Food Research International.2022; 157: 111405.     CrossRef
• Effects of Herbal Therapy on Intestinal Microbiota and Serum Metabolomics in Different Rat Models of Mongolian Medicine
  Guniang Jiu, Riao Dao, Dongxing Wu, Wang Hung, Haburi Jin, Li Li, Xiquan Fu, Chula Sa, Eerdunchaolu, Maulidiani .M
  Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
• The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors
  Tomonori Kamiya, Naoko Ohtani
  International Immunology.2022; 34(9): 467.     CrossRef
• Reduced Cytokine Tumour Necrosis Factor by Pharmacological Intervention in a Preclinical Study
  Armin Mooranian, Jacqueline Chester, Edan Johnston, Corina Mihaela Ionescu, Daniel Walker, Melissa Jones, Susbin Raj Wagle, Bozica Kovacevic, Thomas Foster, Momir Mikov, Hani Al-Salami
  Biomolecules.2022; 12(7): 877.     CrossRef
• Crisis of the Asian gut: associations among diet, microbiota, and metabolic diseases
  Phatthanaphong THERDTATHA, Akari SHINODA, Jiro NAKAYAMA
  Bioscience of Microbiota, Food and Health.2022; 41(3): 83.     CrossRef
• Valorization of avocado seeds with antioxidant capacity using pressurized hot water extraction
  Eng Shi Ong, Janelle Low, Joseph Choon Wee Tan, Su Yi Foo, Chen Huei Leo
  Scientific Reports.2022;[Epub]     CrossRef
• The fungicide prothioconazole and its metabolite prothioconazole-desthio disturbed the liver-gut axis in mice
  Lingyu Hu, Xiaofang Wang, Zhiwei Bao, Qihao Xu, Mingrong Qian, Yuanxiang Jin
  Chemosphere.2022; 307: 136141.     CrossRef
• Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study
  Yueh-Hsiang Huang, Yi-Hong Wu, Hsiang-Yu Tang, Szu-Tah Chen, Chih-Ching Wang, Wan-Jing Ho, Yi-Hsuan Lin, Geng-Hao Liu, Pei-Yeh Lin, Chi-Jen Lo, Yuan-Ming Yeh, Mei-Ling Cheng
  Pharmaceutics.2022; 14(9): 1857.     CrossRef
• Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
  Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri
  Biology.2022; 11(11): 1622.     CrossRef
• The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications
  Shuwen Zhang, Junteng Zhou, Wenchao Wu, Ye Zhu, Xiaojing Liu
  Aging and disease.2022;[Epub]     CrossRef
• Role of bile acids in overweight and obese children and adolescents
  Cosimo Giannini, Concetta Mastromauro, Serena Scapaticci, Cristina Gentile, Francesco Chiarelli
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Bile acids and microbes in metabolic disease
  Dhiraj Kumar Sah, Archana Arjunan, Sun Young Park, Young Do Jung
  World Journal of Gastroenterology.2022; 28(48): 6846.     CrossRef
• The Fungicide Prothioconazole and its Metabolite Prothioconazole-Desthio Disturbed the Liver-Gut Axis in Mice
  Yuanxiang Jin, Lingyu Hu, Xiaofang Wang, Zhiwei Bao, Qihao Xu, Mingrong Qian
  SSRN Electronic Journal .2022;[Epub]     CrossRef
• The Critical Effect of Bile Acids in Atherosclerosis
  Shangwen Qi, Xu Luo, Shuangfang Liu, Bishi Ling, Hua Jin
  Journal of Cardiovascular Pharmacology.2022; 80(4): 562.     CrossRef
• Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells
  Ye-Jee Lee, Esder Lee, Young-Hye You, Yu-Bae Ahn, Ki-Ho Song, Ji-Won Kim, Seung-Hyun Ko
  Journal of Drug Targeting.2021; 29(1): 88.     CrossRef
• Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases
  Kanmani Suganya, Taekwon Son, Kyu-Won Kim, Byung-Soo Koo
  Microbial Pathogenesis.2021; 152: 104583.     CrossRef
• Determination of bile acids from human gallbladder by 1H‐MRS—Protocol optimization and estimation of reproducibility
  Peter Vermathen, Gaëlle Diserens, Dino Kröll, Philipp Nett, Guido Stirnimann, Reiner Wiest
  NMR in Biomedicine.2021;[Epub]     CrossRef
• The gut microbiome-bile acid axis in hepatocarcinogenesis
  Liwei Wu, Jiao Feng, Jingjing Li, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai, Chuanyong Guo
  Biomedicine & Pharmacotherapy.2021; 133: 111036.     CrossRef
• Gut microbiome and bile acids in obesity-related diseases
  Rumei Li, Sergio Andreu-Sánchez, Folkert Kuipers, Jingyuan Fu
  Best Practice & Research Clinical Endocrinology & Metabolism.2021; 35(3): 101493.     CrossRef
• Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta
  Phatthanaphong Therdtatha, Yayi Song, Masaru Tanaka, Mariyatun Mariyatun, Maisaroh Almunifah, Nancy Eka Putri Manurung, Siska Indriarsih, Yi Lu, Koji Nagata, Katsuya Fukami, Tetsuo Ikeda, Yuan-Kun Lee, Endang Sutriswati Rahayu, Jiro Nakayama
  Microorganisms.2021; 9(5): 897.     CrossRef
• Microbial Ecosystem in Diabetes Mellitus: Consideration of the Gastrointestinal System
  Awgichew Shewasinad Yehualashet, Berhan Begashaw Yikna
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 1841.     CrossRef
• Role of bile acids in inflammatory liver diseases
  Ioannis Evangelakos, Joerg Heeren, Esther Verkade, Folkert Kuipers
  Seminars in Immunopathology.2021; 43(4): 577.     CrossRef
• Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes
  Alessandro Mantovani, Andrea Dalbeni, Denise Peserico, Filippo Cattazzo, Michele Bevilacqua, Gian Luca Salvagno, Giuseppe Lippi, Giovanni Targher, Elisa Danese, Cristiano Fava
  Metabolites.2021; 11(7): 453.     CrossRef
• Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice
  Xue-Song Zhang, Yue Sandra Yin, Jincheng Wang, Thomas Battaglia, Kimberly Krautkramer, Wei Vivian Li, Jackie Li, Mark Brown, Meifan Zhang, Michelle H. Badri, Abigail J.S. Armstrong, Christopher M. Strauch, Zeneng Wang, Ina Nemet, Nicole Altomare, Joseph C
  Cell Host & Microbe.2021; 29(8): 1249.     CrossRef
• Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature
  Sarah Kim, Sora Choi, Moumita Dutta, Jeffrey O. Asubonteng, Marianne Polunas, Michael Goedken, Frank J. Gonzalez, Julia Yue Cui, Maxwell A. Gyamfi
  Biochemical Pharmacology.2021; 193: 114698.     CrossRef
• Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products
  Fan Xia, Lu-Ping Wen, Bing-Chen Ge, Yu-Xin Li, Fang-Ping Li, Ben-Jie Zhou
  World Journal of Diabetes.2021; 12(8): 1146.     CrossRef
• Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus
  Youngae Jung, Bo Kyung Koo, Seo Young Jang, Dain Kim, Heeyeon Lee, Dong Hyeon Lee, Sae Kyung Joo, Yong Jin Jung, Jeong Hwan Park, Taekyeong Yoo, Murim Choi, Min Kyung Lee, Sang Won Kang, Mee Soo Chang, Won Kim, Geum‐Sook Hwang
  Liver International.2021; 41(12): 2892.     CrossRef
• Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
  Michele Biagioli, Stefano Fiorucci
  Liver Research.2021; 5(3): 119.     CrossRef
• Synthesis of 12β-Methyl-18-nor-bile Acids
  Andreas Luxenburger, Lawrence D. Harris, Elizabeth M. Ure, Roselis A. Landaeta Aponte, Anthony D. Woolhouse, Scott A. Cameron, Chris D. Ling, Ross O. Piltz, Andrew R. Lewis, Graeme J. Gainsford, Alex Weymouth-Wilson, Richard H. Furneaux
  ACS Omega.2021; 6(38): 25019.     CrossRef
• Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
  Kamil Borkowski, Ameer Y. Taha, Theresa L. Pedersen, Philip L. De Jager, David A. Bennett, Matthias Arnold, Rima Kaddurah-Daouk, John W. Newman
  Scientific Reports.2021;[Epub]     CrossRef
• Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids
  Xunxun Feng, Guangyao Zhai, Jiaqi Yang, Yang Liu, Yujie Zhou, Qianyun Guo
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• An Integrated Bile Acids Profile Determination by UHPLC-MS/MS to Identify the Effect of Bile Acids Supplement in High Plant Protein Diet on Common Carp (Cyprinus carpio)
  Xian Wei, Ting Yao, Fatou Ndoye Fall, Min Xue, Xiaofang Liang, Jie Wang, Wenlong Du, Xu Gu
  Foods.2021; 10(10): 2465.     CrossRef
• Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study
  Jun Hyung Kim, Jin Sil Moon, Seok Joon Byun, Jun Hyeok Lee, Dae Ryong Kang, Ki Chul Sung, Jang Young Kim, Ji Hye Huh
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Methionine restriction alleviates high-fat diet-induced obesity: Involvement of diurnal metabolism of lipids and bile acids
  Luanfeng Wang, Bo Ren, Qian Zhang, Chuanqi Chu, Zhenting Zhao, Jianbin Wu, Weiyang Zhao, Zhigang Liu, Xuebo Liu
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(11): 165908.     CrossRef
• Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes
  Yingjie Wu, An Zhou, Li Tang, Yuanyuan Lei, Bo Tang, Linjing Zhang
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
  John Y. L. Chiang, Jessica M. Ferrell
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2020; 318(3): G554.     CrossRef
• Imidacloprid disturbed the gut barrier function and interfered with bile acids metabolism in mice
  Guiling Yang, Xianling Yuan, Cuiyuan Jin, Dou Wang, Yanhua Wang, Wenyu Miao, Yuanxiang Jin
  Environmental Pollution.2020; 266: 115290.     CrossRef
• Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis
  John Y.L. Chiang, Jessica M. Ferrell
  Liver Research.2020; 4(2): 47.     CrossRef
• Diabetes and Metabolism Journal in 2020: Good to Great
  In-Kyung Jeong
  Diabetes & Metabolism Journal.2020; 44(1): 1.     CrossRef
• Healthy dietary patterns to reduce obesity-related metabolic disease: polyphenol-microbiome interactions unifying health effects across geography
  Camilla Diotallevi, Francesca Fava, Marco Gobbetti, Kieran Tuohy
  Current Opinion in Clinical Nutrition & Metabolic Care.2020; 23(6): 437.     CrossRef
• Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies novel predictors of pre-term delivery
  Ilhame Diboun, Manjunath Ramanjaneya, Yasser Majeed, Lina Ahmed, Mohammed Bashir, Alexandra E. Butler, Abdul Badi Abou-Samra, Stephen L. Atkin, Nayef A. Mazloum, Mohamed A. Elrayess
  Journal of Translational Medicine.2020;[Epub]     CrossRef
• Quantification of common and planar bile acids in tissues and cultured cells
  Stephanie J. Shiffka, Jace W. Jones, Linhao Li, Ann M. Farese, Thomas J. MacVittie, Hongbing Wang, Peter W. Swaan, Maureen A. Kane
  Journal of Lipid Research.2020; 61(11): 1524.     CrossRef
• Influência da microbiota intestinal na Doença Hepática Gordurosa Não Alcoólica
  Isadora Barbosa de Almeida, Wermerson Assunção Barroso, Caroline Amélia Gonçalves
  Revista Científica Multidisciplinar Núcleo do Conhecimento.2020; : 14.     CrossRef
• Ultra-Early and Early Changes in Bile Acids and Insulin after Sleeve Gastrectomy among Obese Patients
  Adriana Florinela Cӑtoi, Alina Elena Pârvu, Aurel Mironiuc, Horațiu Silaghi, Ioana Delia Pop, Andra Diana Andreicuț
  Medicina.2019; 55(12): 757.     CrossRef